Imaging for cardiotoxicity in cancer patients

Texas Heart Institute Journal

Volumn 38, Issue 3, 2011, Pages 268-269

  Banchs, Jose ^a   Jefferies, John L ^b   Plana, Juan Carlos ^c   Hundley, W Gregory ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Cardiovascular Medicine   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE;

ARTERIAL STIFFNESS; ARTICLE; CANCER PATIENT; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIASTOLE; ECHOCARDIOGRAPHY; GOLD STANDARD; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; NONHUMAN; SIDE EFFECT; STRAIN ECHOCARDIOGRAPHY; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; DIAGNOSTIC IMAGING; HEART DISEASES; HUMANS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 79959924520     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Mor-Avi V, Sugeng L, Weinert L, MacEneaney P, Caiani EG, Koch R, et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 2004;110(13): 1814-8.
2. Bu L, Munns S, Zhang H, Disterhoft M, Dixon M, Stolpen A, et al. Rapid full volume data acquisition by real-time 3-dimensional echocardiography for assessment of left ventricularindexes in children: a validation study compared with magnetic resonance imaging. J Am Soc Echocardiogr 2005;18(4): 299-305.
3. Dorup I, Levitt G, Sullivan I, Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function. Heart 2004; 90(10):1214-6.
4. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications [published erratum appears in J Am Soc Echocardiogr 2010;23(7):734]. J Am Soc Echocardiogr 2010;23(4):351-69.
5. Brown J, Jenkins C, Marwick TH. Use of myocardial strain to assess global left ventricular function: a comparison with cardiac magnetic resonance and 3-dimensional echocardiography. Am Heart J 2009;157(1):102.e1-5.
6. Piegari E, Di Salvo G, Castaldi B, Vitelli MR, Rodolico G, Golino P, et al. Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model. Ultrasound Med Biol 2008;34 (3):370-8.
7. Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment withtrastuzumab. Am Heart J 2009;158(2):294-301.
8. Lightfoot JC, D'Agostino RB Jr, Hamilton CA, Jordan J, Torti FM, Kock ND, et al. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model. Circ Cardiovasc Imaging 2010;3(5):550-8.
9. Chaosuwannakit N, D'Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, et al. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol 2010;28(1):166-72.